[1]
Silva, R.B. 2019. Empaglifozin cardiovascular benefit: can we separate fact from fiction?. Journal of Evidence-Based Healthcare. 1, 1 (Jun. 2019), 43–45. DOI:https://doi.org/10.17267/2675-021Xevidence.v1i1.2095.